Thymosin Beta-4 Fragment
Dragon Pharma Peptide Product
Dragon Pharma TB 500 is supplied as a lyophilized powder in a 2 mL vial and contains the synthetic peptide fragment thymosin beta-4 at a labeled strength of 5 mg. Product specifications, batch-specific lab reports, storage information, and available payment options are provided below.
Each vial contains a labeled strength of 5 mg of TB 500.
Supplied as a freeze-dried powder that requires reconstitution with bacteriostatic water before use.
Packaged in a standard 2 mL peptide vial with a rubber stopper and aluminum seal.
Multiple published lab reports provide measured results across different test dates and batches.
| Product name | TB 500 5 mg |
|---|---|
| Active substance | Thymosin Beta-4 |
| Labeled strength | 5 mg/vial |
| Container | 2 mL vial |
| Total labeled content | 5 mg per vial |
| Product form | Lyophilized powder |
| Manufacturer | Dragon Pharma |
The latest published report for batch #TBHO23, dated March 22, 2024, measured 6.15 mg against the stated 5 mg labeled strength. A previous report from September 25, 2023, measured 6.31 mg for batch #TBHD23.
Open the Lab Reports tab to view the full reports and compare results across test dates.
Other peptide options from the same product line include BPC-157 5 mg, another peptide investigated for tissue repair research, and Glow 60 mg, which combines TB-500 with BPC-157 and GHK-CU. These products differ in their peptide composition and research applications.
Published Testing History
Published lab reports for Dragon Pharma TB 500 5 mg are provided below with the test dates, measured results and reported batch numbers. Each result can be compared directly with the product's labeled strength of 5 mg.
Science & Research
TB 500 is a synthetic peptide that corresponds to a fragment of the naturally occurring protein thymosin beta-4. This section provides a brief overview of what is known about this peptide from research literature.
TB 500 is a synthetic peptide that corresponds to a fragment of the naturally occurring protein thymosin beta-4. It has been investigated in preclinical research for its potential role in cell migration and tissue repair.
Preclinical research has investigated TB 500 for its potential effects on tissue repair and related cellular processes. The peptide has been studied in laboratory settings for its interactions with cellular pathways involved in tissue maintenance.
The precise mechanism of action of TB 500 is not fully characterized. Research suggests it may influence cell migration and cytoskeletal regulation, though the exact molecular mechanisms remain an area of ongoing investigation.
This product is supplied as a lyophilized powder and must be reconstituted with bacteriostatic water or sterile water for injection before use. The addition of water converts the freeze-dried powder into a solution suitable for research applications.
The reconstituted peptide solution should be stored as recommended on the product label. Peptide solutions are typically refrigerated and used within a specified timeframe after reconstitution to maintain integrity.
Peer-reviewed research on thymosin beta-4 is available through the National Institutes of Health and other scientific databases. The following link provides general information on this peptide and its mechanism of action.
Important Health Information
Peptide research compounds such as TB 500 have limited clinical safety data. The information below is derived from published preclinical research and general knowledge of peptide biology and does not constitute medical advice.
TB 500 has not been extensively studied in humans. The available safety information comes primarily from preclinical research.
Subcutaneous injection carries risks including injection-site reactions, infection and improper technique. Sterile handling and correct reconstitution procedures are essential.
The potential systemic effects of TB 500 and its interactions with other physiological systems are not fully understood.
This peptide research compound should not be used by individuals with known allergies or sensitivities to peptide compounds, or by those who are pregnant, nursing or have active malignancies.
The long-term effects and safety profile of TB 500 have not been established in any population. Research on this peptide is still in the early stages.
The full range of immunological effects of TB 500, including its potential influence on immune function, is not fully characterized in a clinical context.
Medical advice is particularly important for individuals with autoimmune conditions, cancer or a history of cancer, cardiovascular disease, or those taking medications that affect immune function. This peptide should not be used during pregnancy or breastfeeding.
The product should also be stored securely to prevent accidental access or use by children or other household members, particularly after reconstitution when it contains a liquid solution.
TB 500 (thymosin beta-4) is not specifically listed on the World Anti-Doping Agency Prohibited List at the time of writing. Athletes should check the current list before competition, as prohibited substances are subject to change. Some peptide compounds may fall under general prohibitions on substances with similar biological effects.
The current status and applicable rules can be checked through the World Anti-Doping Agency Prohibited List.
Common Product Questions
Quick answers about TB 500 5 mg specifications, the published lab reports, storage, shipping, Bitcoin payment and general product information.
Dragon Pharma TB 500 5 mg is a lyophilized peptide product containing 5 mg of the thymosin beta-4 fragment TB 500 per vial. It is supplied in a 2 mL vial for research purposes.
TB 500 is a synthetic peptide that corresponds to a fragment of the naturally occurring protein thymosin beta-4. It has been investigated in preclinical research for its potential role in tissue repair and related cellular processes.
Each vial contains a labeled strength of 5 mg of TB 500.
The product is supplied as a lyophilized powder in a 2 mL vial. It requires reconstitution with bacteriostatic water or sterile water for injection before use.
The latest published report, dated March 22, 2024, measured 6.15 mg for batch #TBHO23. A previous report from September 25, 2023, measured 6.31 mg for batch #TBHD23.
Multiple reports provide a testing history across different dates and batches instead of relying on a single result. The batch number printed on a vial can be compared with the batch numbers listed in the Lab Reports tab to find a corresponding published test.
No. Each report applies to the sample submitted for that specific test and the batch identified in the report. It does not independently verify the content or condition of every individual vial.
Store the lyophilized powder in its original packaging at room temperature or refrigerated, protected from excessive heat, moisture and direct light. Once reconstituted, peptide solutions typically require refrigeration and should be used within a limited timeframe. Always follow the specific storage directions printed on the product label.
Lyophilized peptide powders are generally stable at room temperature but should be protected from heat. After reconstitution, peptide solutions typically require refrigeration. Check the product label for specific storage instructions.
Delivery depends on the warehouse selected for the order. Shipments from the USA Warehouse typically take 4–5 business days after dispatch, while shipments from the International Warehouse typically take 15–20 business days after dispatch. Full delivery and reship information is available on the Shipping Information page.
Yes. Bitcoin and other supported cryptocurrencies are available at checkout for all orders. To buy TB 500 5 mg with Bitcoin, select Bitcoin as the payment method during checkout and follow the payment instructions provided with the order.
Bitcoin transactions are recorded on a public blockchain and should not be considered automatically anonymous. Accurate order and delivery information is still required for order processing and shipping.
TB 500 is not specifically listed on the World Anti-Doping Agency Prohibited List at the time of writing. Athletes should check the current list before competition, as prohibited substances are subject to change.
Additional research on this peptide is available through the National Institutes of Health and other scientific databases. A direct link to PubMed references is provided in the Science & Research section above.